Improving Patient Outcomes with AI-Powered Pathology At PathAI, we’re dedicated to improving patient outcomes with reliable AI-Powered technology and meaningful collaboration with biopharma, laboratories, and clinicians — aiming to provide patients with access to accurate diagnoses and effective treatments.
Introducing AISight, the Digital Pathology Image Management System from PathAI AISightTM is a cloud-native intelligent enterprise workflow solution used by the world's leading laboratories and research centers to power their digital pathology workflows and AI applications. It serves as a central hub for case management, image management, and best-in-class artificial intelligence tools to enable multiple histopathology use cases.
AISight® Digital Pathology Platform: A cloud-native, open platform for managing digital pathology workflows and integrating AI applications for case and image management.
AI Product Solutions: Offers a comprehensive suite of algorithms for workflow optimization, biomarker quantification, and AI-assisted research tools tailored for pathology.
Real-World Data Integration: Combines quantitative histopathology data with clinico-genomic datasets to enhance drug development and clinical trial design.
IHCExplore™: Provides AI-powered quantification of immunohistochemistry assays, enabling detailed analysis of biomarker expression at cellular and subcellular levels.
LiverExplore™: An AI-powered tool that characterizes liver biopsy microarchitecture, offering over 1,000 quantitative features for research in liver diseases.
AI-Powered Biomarker Quantification: Utilizes IHCExplore™ to enhance biomarker discovery and quantification through automated analysis of Immunohistochemistry (IHC) slide images.
Clinical Trial Support: Provides trial-ready algorithms and comprehensive lab services to facilitate patient enrollment, stratification, and endpoint measurement in clinical trials.
Real-World Data Integration: Licenses quantitative histopathology data linked to clinical and molecular data to identify prognostic biomarkers and validate findings from translational research.
Digital Pathology Solutions: Offers AISight® digital pathology platforms for case and image management, enabling efficient workflows in anatomic pathology laboratories.
Custom Algorithm Development: Develops tailored AI algorithms for various disease categories, enhancing research capabilities in oncology, immunology, and inflammation.
Provides AI-powered insights for biomarker discovery and quantification, enhancing treatment strategies and patient stratification.
Offers advanced workflow optimization tools to improve efficiency and productivity in anatomic pathology labs.
Delivers comprehensive and rapid biomarker quantification, ensuring accuracy and reproducibility in scoring.
Integrates quantitative pathology data with real-world data to uncover novel biomarkers and enhance clinical development.
Supports clinical trial success with trial-ready algorithms and comprehensive lab services for patient enrollment and endpoint measurement.
AISight®️ Dx Digital Pathology Platform (FDA 510(k) cleared) and AISight®️ Dx Digital Pathology Platform (CE-IVDR marked) are available for use, with specific consult services offered.
IHCExplore™ provides AI-powered biomarker quantification for research use only, focusing on Immunohistochemistry (IHC) assays.
LiverExplore™ offers over 1,000 quantitative Human Interpretable Features (HIFs) for research use only, specifically targeting liver tissue characterization.
PathAI's algorithm products, including AIM-PD-L1 and AIM-IHC Breast Panel, are designated for research use only and not for diagnostic procedures.
All products and services are primarily intended for research purposes, with no specific pricing details provided in the text.
